approval
saveVYALEV (FOSCARBIDOPA) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: SOLUTION. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 1
same company · ±60 days · 6
- approvalcarbidopa: DUOPA (CARBIDOPA) — FDA approvalMar 19, 2026
- approvalrisankizumab: SKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalMar 18, 2026
- approvalrisankizumab: SKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalMar 18, 2026
- approvalLumify: COMBIGAN (BRIMONIDINE TARTRATE) — FDA approvalMar 17, 2026
- approvaldexamethasone LA: OZURDEX (DEXAMETHASONE) — FDA approvalMar 11, 2026
- approvalESCITALOPRAM OXALATE — FDA approvalMar 27, 2026
comments(0)
5-min edit window · permanent after that